Article ; Online: A dual inhibitor targeting HMG-CoA reductase and histone deacetylase mitigates neurite degeneration in
Aging
2020 Volume 12, Issue 24, Page(s) 25581–25598
Abstract: Parkinson's disease (PD) is among the most common neurodegenerative disorders, and its etiology involves both genetic and environmental factors. The leucine-rich repeat kinase (LRRK2) G2019S mutation is the most common genetic cause of familial and ... ...
Abstract | Parkinson's disease (PD) is among the most common neurodegenerative disorders, and its etiology involves both genetic and environmental factors. The leucine-rich repeat kinase (LRRK2) G2019S mutation is the most common genetic cause of familial and sporadic PD. Current treatment is limited to dopaminergic supplementation, as no disease-modifying therapy is available yet. Recent evidence reveals that HMG-CoA reductase (HMGR) inhibitors (statins) exert neuroprotection through anti-neuroinflammatory effects, and histone deacetylase (HDAC) inhibitors mitigate neurodegeneration by promoting the transcription of neuronal survival factors. We designed and synthesized a dual inhibitor, statin hydroxamate JMF3086, that simultaneously inhibits HMGR and HDAC, and examined its neuroprotective effects on |
---|---|
MeSH term(s) | Animals ; Drosophila ; Hippocampus/drug effects ; Hippocampus/metabolism ; Hippocampus/pathology ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylase Inhibitors/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/metabolism ; Mice ; Mice, Transgenic ; Nerve Degeneration/drug therapy ; Nerve Degeneration/metabolism ; Nerve Degeneration/pathology ; Neurites/drug effects ; Neurites/metabolism ; Neurites/pathology ; Neuronal Outgrowth/drug effects ; Neurons/drug effects ; Neurons/metabolism ; Neurons/pathology ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Parkinsonian Disorders/drug therapy ; Parkinsonian Disorders/genetics ; Parkinsonian Disorders/metabolism ; Parkinsonian Disorders/pathology ; Phosphorylation/drug effects |
Chemical Substances | Histone Deacetylase Inhibitors ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Neuroprotective Agents ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 (EC 2.7.11.1) |
Language | English |
Publishing date | 2020-11-24 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ISSN | 1945-4589 |
ISSN (online) | 1945-4589 |
DOI | 10.18632/aging.104165 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.